Literature DB >> 23980110

Cellular response to Trypanosoma cruzi infection induces secretion of defensin α-1, which damages the flagellum, neutralizes trypanosome motility, and inhibits infection.

Candice A Johnson1, Girish Rachakonda, Yuliya Y Kleshchenko, Pius N Nde, M Nia Madison, Siddharth Pratap, Tatiana C Cardenas, Chase Taylor, Maria F Lima, Fernando Villalta.   

Abstract

Human defensins play a fundamental role in the initiation of innate immune responses to some microbial pathogens. Here we show that colonic epithelial model HCT116 cells respond to Trypanosoma cruzi infection by secreting defensin α-1, which reduces infection. We also report the early effects of defensin α-1 on invasive trypomastigotes that involve damage of the flagellar structure to inhibit parasite motility and reduce cellular infection. Short exposure of defensin α-1 to trypomastigotes shows that defensin α-1 binds to the flagellum, resulting in flagellar membrane and axoneme alterations, followed by breaking of the flagellar membrane connected to the trypanosome body, leading to detachment and release of the parasite flagellum. In addition, defensin α-1 induces a significant reduction in parasite motility in a peptide concentration-dependent manner, which is abrogated by anti-defensin α-1 IgG. Preincubation of trypomastigotes with a concentration of defensin α-1 that inhibits 50% trypanosome motility significantly reduced cellular infection by 80%. Thus, human defensin α-1 is an innate immune molecule that is secreted by HCT116 cells in response to T. cruzi infection, inhibits T. cruzi motility, and plays an important role in reducing cellular infection. This is the first report showing a novel cellular innate immune response to a human parasite by secretion of defensin α-1, which neutralizes the motility of a human parasite to reduce cellular infection. The mode of activity of human defensin α-1 against T. cruzi and its function may provide insights for the development of new antiparasitic strategies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23980110      PMCID: PMC3811821          DOI: 10.1128/IAI.01459-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

Review 1.  Multifunctional host defense peptides: antiparasitic activities.

Authors:  Amram Mor
Journal:  FEBS J       Date:  2009-10-09       Impact factor: 5.542

2.  Infectious diseases. Drug developers finally take aim at a neglected disease.

Authors:  Mitch Leslie
Journal:  Science       Date:  2011-08-19       Impact factor: 47.728

Review 3.  Targeting Trypanosoma cruzi sterol 14α-demethylase (CYP51).

Authors:  Galina I Lepesheva; Fernando Villalta; Michael R Waterman
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

4.  Human alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequences.

Authors:  Chun Kim; Nadesan Gajendran; Hans-Willi Mittrücker; Matthias Weiwad; Young-Hwa Song; Robert Hurwitz; Matthias Wilmanns; Gunter Fischer; Stefan H E Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-16       Impact factor: 11.205

5.  Elevated concentrations of human neutrophil peptides in plasma, blood, and body fluids from patients with infections.

Authors:  T Ihi; M Nakazato; H Mukae; S Matsukura
Journal:  Clin Infect Dis       Date:  1997-11       Impact factor: 9.079

6.  The membrane-bound structure and topology of a human α-defensin indicate a dimer pore mechanism for membrane disruption.

Authors:  Yuan Zhang; Wuyuan Lu; Mei Hong
Journal:  Biochemistry       Date:  2010-10-26       Impact factor: 3.162

7.  Role of inflammatory cells in Chagas' disease. II. Interactions of mouse macrophages and human monocytes with intracellular forms of Trypanosoma cruzi: uptake and mechanism of destruction.

Authors:  F Villalta; F Kierszenbaum
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

Review 8.  Paneth cell defensins: endogenous peptide components of intestinal host defense.

Authors:  A J Ouellette; M E Selsted
Journal:  FASEB J       Date:  1996-09       Impact factor: 5.191

9.  Mechanism of adenovirus neutralization by Human alpha-defensins.

Authors:  Jason G Smith; Glen R Nemerow
Journal:  Cell Host Microbe       Date:  2008-01-17       Impact factor: 21.023

10.  Defensins. Natural peptide antibiotics of human neutrophils.

Authors:  T Ganz; M E Selsted; D Szklarek; S S Harwig; K Daher; D F Bainton; R I Lehrer
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

View more
  10 in total

1.  Entamoeba histolytica Alters Ileal Paneth Cell Functions in Intact and Muc2 Mucin Deficiency.

Authors:  Eduardo R Cobo; Ravi Holani; France Moreau; Kiminori Nakamura; Tokiyoshi Ayabe; Jennifer R Mastroianni; Yoshihiro Eriguchi; Andre Ouellette; Kris Chadee
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

2.  Expression of α-Defensins, CD20+ B-lymphocytes, and Intraepithelial CD3+ T-lymphocytes in the Intestinal Mucosa of Patients with Liver Cirrhosis: Emerging Mediators of Intestinal Barrier Function.

Authors:  Georgios I Tsiaoussis; Eleni C Papaioannou; Eleni P Kourea; Stelios F Assimakopoulos; Georgios I Theocharis; Michalis Petropoulos; Vasileios I Theopistos; Georgia G Diamantopoulou; Zoi Lygerou; Iris Spiliopoulou; Konstantinos C Thomopoulos
Journal:  Dig Dis Sci       Date:  2018-06-07       Impact factor: 3.199

3.  Sterol 14α-Demethylase Structure-Based Optimization of Drug Candidates for Human Infections with the Protozoan Trypanosomatidae.

Authors:  Laura Friggeri; Tatiana Y Hargrove; Girish Rachakonda; Anna L Blobaum; Paxtyn Fisher; Gabriel Melo de Oliveira; Cristiane França da Silva; Maria de Nazaré C Soeiro; W David Nes; Craig W Lindsley; Fernando Villalta; F Peter Guengerich; Galina I Lepesheva
Journal:  J Med Chem       Date:  2018-11-30       Impact factor: 7.446

4.  Clinical Candidate VT-1161's Antiparasitic Effect In Vitro, Activity in a Murine Model of Chagas Disease, and Structural Characterization in Complex with the Target Enzyme CYP51 from Trypanosoma cruzi.

Authors:  William J Hoekstra; Tatiana Y Hargrove; Zdzislaw Wawrzak; Denise da Gama Jaen Batista; Cristiane F da Silva; Aline S G Nefertiti; Girish Rachakonda; Robert J Schotzinger; Fernando Villalta; Maria de Nazaré C Soeiro; Galina I Lepesheva
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

5.  Immunization with Hexon modified adenoviral vectors integrated with gp83 epitope provides protection against Trypanosoma cruzi infection.

Authors:  Anitra L Farrow; Girish Rachakonda; Linlin Gu; Valentina Krendelchtchikova; Pius N Nde; Siddharth Pratap; Maria F Lima; Fernando Villalta; Qiana L Matthews
Journal:  PLoS Negl Trop Dis       Date:  2014-08-21

6.  Epitope Capsid-Incorporation: New Effective Approach for Vaccine Development for Chagas Disease.

Authors:  Qiana L Matthews; Anitra L Farrow; Girish Rachakonda; Linlin Gu; Pius Nde; Alexandre Krendelchtchikov; Siddharth Pratap; Shruti S Sakhare; Steffanie Sabbaj; Maria F Lima; Fernando Villalta
Journal:  Pathog Immun       Date:  2016 Fall-Winter

7.  Structural basis for rational design of inhibitors targeting Trypanosoma cruzi sterol 14α-demethylase: two regions of the enzyme molecule potentiate its inhibition.

Authors:  Laura Friggeri; Tatiana Y Hargrove; Girish Rachakonda; Amanda D Williams; Zdzislaw Wawrzak; Roberto Di Santo; Daniela De Vita; Michael R Waterman; Silvano Tortorella; Fernando Villalta; Galina I Lepesheva
Journal:  J Med Chem       Date:  2014-07-29       Impact factor: 7.446

8.  Experimental and Mathematical-Modeling Characterization of Trypanosoma cruzi Epimastigote Motility.

Authors:  Eduardo Sosa-Hernández; Gilberto Ballesteros-Rodea; Jorge A Arias-Del-Angel; Diego Dévora-Canales; Rebeca G Manning-Cela; Jesús Santana-Solano; Moisés Santillán
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

9.  Establishment of Larval Zebrafish as an Animal Model to Investigate Trypanosoma cruzi Motility In Vivo.

Authors:  Veronica Akle; Nathalie Agudelo-Dueñas; Maria A Molina-Rodriguez; Laurel Brianne Kartchner; Annette Marie Ruth; John M González; Manu Forero-Shelton
Journal:  J Vis Exp       Date:  2017-09-30       Impact factor: 1.355

10.  Motility patterns of Trypanosoma cruzi trypomastigotes correlate with the efficiency of parasite invasion in vitro.

Authors:  Jorge A Arias-Del-Angel; Jesús Santana-Solano; Moisés Santillán; Rebeca G Manning-Cela
Journal:  Sci Rep       Date:  2020-09-28       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.